Product Details

Oxmax 65 mg/ml Solution for Infusion for Dogs

• MA holder: New Alpha Innovation Biopharmaceutical Ireland Limited
• VM number: 51132/5000
• Territory: Great Britain
• Associated documents:
  • View Summary of Product Characteristics
  • View Product Literature (labelling and package leaflet text)
  • View Public Assessment Report
• Date of issue: 28/11/2023
• Authorisation route: National
• Active substances:
  • Hemoglobin betafumaril (bovine)
• Controlled drug: No
• Target species:
  • Dogs
• Distribution category: POM-V
• Distributors:
  • New Alpha Innovation Biopharmaceutical Ireland Limited